World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
113
Citations
71909
World Ranking
4834
National Ranking
475

Research.com Recognitions

  • 2014 - Fellow of the American Society of Mechanical Engineers

Overview

John D. Hainsworth is affiliated with the Sarah Cannon Research Institute in the United Kingdom. Their research contributions span multiple areas within medicine, with a focus on oncology and related biomedical sciences.

The fields of study in which Hainsworth has published include Medicine and Biochemistry, Genetics and Molecular Biology. Subfields particularly represented in their work are Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, and Cancer Research.

The main research topics addressed by Hainsworth include:

  • Renal cell carcinoma treatment
  • Renal and related cancers
  • Peptidase Inhibition and Analysis
  • Cancer Immunotherapy and Biomarkers
  • HER2/EGFR in Cancer Research
  • Advanced Breast Cancer Therapies
  • Cancer Genomics and Diagnostics

They have contributed to publications in well-known scientific venues, including:

  • Cancer Research
  • The Lancet Oncology
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Kidney Cancer Journal

Frequent co-authors in their research include Razelle Kurzrock, Howard A. Burris, Funda Meric-Bernstam, Charles Swanton, and Christopher J. Sweeney.

Representative recent papers authored by John D. Hainsworth include:

  • "Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study", 2021, The Lancet Oncology
  • "Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study", 2022, The Lancet Oncology
  • "Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study", 2020, Annals of Oncology
  • "Atezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket Study", 2021, Cancer Discovery
  • "Cancer of Unknown Primary in the Molecular Era", 2021, Trends in cancer

John D. Hainsworth was recognized as a Fellow of the American Society of Mechanical Engineers in 2014.

Best Publications

  • BEVACIZUMAB PLUS IRINOTECAN, FLUOROURACIL, AND LEUCOVORIN FOR METASTATIC COLORECTAL CANCER

    Herbert Hurwitz;Louis Fehrenbacher;William Novotny;Thomas Cartwright

  • Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

    Howard I. Scher;Karim Fizazi;Fred Saad;Mary-Ellen Taplin

  • Abiraterone and Increased Survival in Metastatic Prostate Cancer

    Johann S. de Bono;Christopher J. Logothetis;Arturo Molina;Karim Fizazi

  • Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma

    Aleksandar Sekulic;Michael R. Migden;Anthony E. Oro;Luc Dirix

  • Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

    Marianne E Pavel;John D Hainsworth;Eric Baudin;Marc Peeters

  • Adjuvant docetaxel for node-positive breast cancer.

    Miguel Martin;Tadeusz Pienkowski;John R Mackey;Marek Pawlicki

  • Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

    David F. McDermott;Mahrukh A. Huseni;Michael B. Atkins;Robert J. Motzer

  • Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer

    Herbert I. Hurwitz;Louis Fehrenbacher;John D. Hainsworth;William Heim

  • Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study

    Howard S. Hochster;Lowell L. Hart;Ramesh K. Ramanathan;Barrett H. Childs

  • Proposal for classifying the acute emetogenicity of cancer chemotherapy.

    Paul J. Hesketh;Mark G. Kris;Steven M. Grunberg;Thomas Beck

  • Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

    Carla Casulo;Michelle Byrtek;Keith L. Dawson;Xiaolei Zhou

  • Diagnostic and therapeutic management of cancer of an unknown primary

    N. Pavlidis;E. Briasoulis;J. Hainsworth;F.A. Greco

  • Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

    F M Muggia;J D Hainsworth;S Jeffers;P Miller

  • Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab

    Frank A. Scappaticci;Louis Fehrenbacher;Thomas Cartwright;John D. Hainsworth

  • Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin’s Lymphoma

    John D. Hainsworth;Sharlene Litchy;Howard A. Burris;Daniel C. Scullin

  • Randomized Phase II Comparison of Dose-Intense Gemcitabine: Thirty-Minute Infusion and Fixed Dose Rate Infusion in Patients With Pancreatic Adenocarcinoma

    Margaret Tempero;William Plunkett;Veronique Ruiz Van Haperen;John Hainsworth

  • Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial

    Roy S Herbst;Rafat Ansari;Frederique Bustin;Patrick Flynn

  • Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network

    John D. Hainsworth;Sharlene Litchy;John H. Barton;Gerry Ann Houston

  • Maximizing Therapeutic Benefit of Rituximab: Maintenance Therapy Versus Re-Treatment at Progression in Patients With Indolent Non-Hodgkin's Lymphoma—A Randomized Phase II Trial of the Minnie Pearl Cancer Research Network

    John D. Hainsworth;Sharlene Litchy;Don W. Shaffer;Van L. Lackey

  • Targeted therapy for advanced solid tumors on the basis of molecular profiles: Results from mypathway, an open-label, phase IIA multiple basket study

    John D. Hainsworth;Funda Meric-Bernstam;Charles Swanton;Herbert Hurwitz

Frequent Co-Authors

David R. Spigel
David R. Spigel Sarah Cannon Research Institute
F. Anthony Greco
F. Anthony Greco Sarah Cannon Research Institute
Howard A. Burris
Howard A. Burris Sarah Cannon Research Institute
David H. Johnson
David H. Johnson The University of Texas Southwestern Medical Center
Herbert Hurwitz
Herbert Hurwitz Duke University
Walter M. Stadler
Walter M. Stadler University of Chicago
Jonathan W. Friedberg
Jonathan W. Friedberg University of Rochester
Jeffrey R. Infante
Jeffrey R. Infante Janssen (Belgium)
Karim Fizazi
Karim Fizazi University of Paris-Saclay
Charles Swanton
Charles Swanton The Francis Crick Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t have to follow a traditional path. Many students expand their healthcare knowledge with flexible online degrees. For instance, those interested in preventive medicine and wellness can consider a nutrition degree online, which opens doors to roles in dietetics, public health, and health education.

For those focused on healthcare leadership and administration, accredited mha programs deliver essential business and management skills, qualifying graduates for managerial roles in hospitals and health systems.

Registered nurses can advance their careers efficiently through rn bsn online programs no clinicals, allowing working professionals to earn their bachelor’s without disrupting their schedules. Additionally, those seeking advanced clinical or leadership nursing roles may opt for accelerated dnp programs, which provide a fast-track to doctoral-level expertise.

Online healthcare degrees offer diverse pathways for career advancement and specialization—ideal for students at every stage of their medical journey.

Best Scientists Citing John D. Hainsworth

Trending Scientists

Recently Published Articles